Literature DB >> 12460608

Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury.

Deborah A Shear1, Rodrique Galani, Stuart W Hoffman, Donald G Stein.   

Abstract

A single injection of progesterone can attenuate cerebral edema when administered during the first 24 h after traumatic brain injury (TBI) in rats but this regimen may not always produce functional benefits. In this experiment, we sought to find the duration of progesterone administration needed to facilitate both behavioral and morphological recovery. Male rats received bilateral contusions of the medial prefrontal cortex and were given progesterone (4 mg/kg) or vehicle for 3 or 5 days postoperatively. Both the 3- and the 5-day progesterone regimens reduced the size of injury- induced necrosis and cell loss, with the 5-day schedule being most effective. With regard to behavioral outcome, only 5 days of progesterone injections resulted in improved spatial learning performance and reduced sensory neglect. These results show that 5 days of postinjury progesterone treatment are needed to reduce significantly the neuropathological and behavioral abnormalities found in a rodent model of TBI. These benefits of progesterone, in the absence of any known side effects, provide further support for clinical testing of this neurosteroid.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460608     DOI: 10.1006/exnr.2002.8020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  45 in total

1.  Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling.

Authors:  Chang Su; Rebecca L Cunningham; Nataliya Rybalchenko; Meharvan Singh
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 2.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

Review 3.  Progesterone exerts neuroprotective effects after brain injury.

Authors:  Donald G Stein
Journal:  Brain Res Rev       Date:  2007-07-27

Review 4.  Multifunctional drugs for head injury.

Authors:  Robert Vink; Alan J Nimmo
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

5.  Progesterone antagonism of neurite outgrowth depends on microglial activation via Pgrmc1/S2R.

Authors:  N Bali; J M Arimoto; T E Morgan; C E Finch
Journal:  Endocrinology       Date:  2013-05-07       Impact factor: 4.736

6.  Progesterone treatment normalizes the levels of cell proliferation and cell death in the dentate gyrus of the hippocampus after traumatic brain injury.

Authors:  Cindy K Barha; Tauheed Ishrat; Jonathan R Epp; Liisa A M Galea; Donald G Stein
Journal:  Exp Neurol       Date:  2011-06-13       Impact factor: 5.330

7.  A Combination Therapy of Nicotinamide and Progesterone Improves Functional Recovery following Traumatic Brain Injury.

Authors:  Todd C Peterson; Michael R Hoane; Keith S McConomy; Fred M Farin; Theo K Bammler; James W MacDonald; Eric D Kantor; Gail D Anderson
Journal:  J Neurotrauma       Date:  2015-02-26       Impact factor: 5.269

Review 8.  Sex-related responses after traumatic brain injury: Considerations for preclinical modeling.

Authors:  Claudia B Späni; David J Braun; Linda J Van Eldik
Journal:  Front Neuroendocrinol       Date:  2018-05-18       Impact factor: 8.606

9.  Neurosteroids reduce inflammation after TBI through CD55 induction.

Authors:  Jacob W VanLandingham; Milos Cekic; Sarah Cutler; Stuart W Hoffman; Donald G Stein
Journal:  Neurosci Lett       Date:  2007-08-25       Impact factor: 3.046

10.  Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice.

Authors:  Denise Harhausen; Uldus Khojasteh; Philip F Stahel; B Paul Morgan; Wilfried Nietfeld; Ulrich Dirnagl; George Trendelenburg
Journal:  J Neuroinflammation       Date:  2010-03-04       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.